Back

ir. drs. A. (Alwin) Link

ir. drs. A. (Alwin) Link

Full Professor

Show full profile

Research Output (242)

Exposure–Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life Setting

Boosman René J., Jebbink Merel, Veldhuis Wouter B., Groenland Stefanie L., van Veggel Bianca A.M.H., Moeskops Pim, de Langen Adrianus J., Beijnen Jos H., Smit Egbert F., Huitema Alwin D.R., Steeghs Neeltje Oct 2022, In: Pharmaceutical Research. 39 , p. 2507-2514 8 p.

A highly sensitive bioanalytical method for the quantification of vinblastine, vincristine, vinorelbine and 4-O-deacetylvinorelbine in human plasma using LC-MS/MS

van der Heijden L T, Gebretensae A, Thijssen B, van Andel L, Nijstad A L, Wang Y, Rosing H, Huitema A D R, Beijnen J H 5 Jun 2022, In: Journal of Pharmaceutical and Biomedical Analysis. 215 , p. 1-8

Is age just a number?:A population pharmacokinetic study of gemcitabine

Boosman René J, Crombag Marie-Rose B S, van Erp Nielka P, Beijnen Jos H, Steeghs Neeltje, Huitema Alwin D R May 2022, In: Cancer Chemotherapy and Pharmacology. 89 , p. 697-705 9 p.

Optimized sample pre-treatment procedure for the simultaneous UPLC-MS/MS quantification of ipilimumab, nivolumab, and pembrolizumab in human serum

de Jong Karen A M, Rosing Hilde, Huitema Alwin D R, Beijnen Jos H 30 Apr 2022, In: Journal of Chromatography B. 1196 , p. 1-9

Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia

Dekker Linde, Calkoen Friso G., Jiang Yilin, Blok Hilly, Veldkamp Saskia R., De Koning Coco, Spoon Maike, Admiraal Rick, Hoogerbrugge Peter, Vormoor Britta, Vormoor H. Josef, Visscher Henk, Bierings Marc, Van Der Vlugt Marieke, Van Tinteren Harm, Nijstad A. Laura, Huitema Alwin D.R., Van Der Elst Kim C.M., Pieters Rob, Lindemans Caroline A., Nierkens Stefan 12 Apr 2022, In: Blood Advances. 6 , p. 1969-1976 8 p.

Ritonavir-Boosted Exposure of Kinase Inhibitors:an Open Label, Cross-over Pharmacokinetic Proof-of-Concept Trial with Erlotinib

Boosman René J, de Gooijer Cornedine J, Groenland Stefanie L, Burgers Jacobus A, Baas Paul, van der Noort Vincent, Beijnen Jos H, Huitema Alwin D R, Steeghs Neeltje Apr 2022, In: Pharmaceutical Research. 39 , p. 669-676 8 p.

Toxicity and efficacy of chronomodulated chemotherapy:a systematic review

Printezi Markella I, Kilgallen Aoife B, Bond Marinde J G, Štibler Urška, Putker Marrit, Teske Arco J, Cramer Maarten J, Punt Cornelis J A, Sluijter Joost P G, Huitema Alwin D R, May Anne M, van Laake Linda W Mar 2022, In: LANCET ONCOLOGY. 23 , p. e129-e143

Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity

Laoukili Jamila, Constantinides Alexander, Wassenaar Emma C E, Elias Sjoerd G, Raats Danielle A E, van Schelven Susanne J, van Wettum Jonathan, Volckmann Richard, Koster Jan, Huitema Alwin D R, Nienhuijs Simon W, de Hingh Ignace H J T, Wiezer René J, van Grevenstein Helma M U, Rinkes Inne H M Borel, Boerma Djamila, Kranenburg Onno 22 Feb 2022, In: British Journal of Cancer. 126 , p. 1824-1833 10 p.

Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy in Children with Cancer:A Systematic Review and Meta-Analysis

Uittenboogaard Aniek, Neutel Céline L G, Ket Johannes C F, Njuguna Festus, Huitema Alwin D R, Kaspers Gertjan J L, van de Velde Mirjam E 1 Feb 2022, In: Cancers. 14 , p. 1-24

Everolimus Concentration in Saliva to Predict Stomatitis:A Feasibility Study in Patients with Cancer

Laura Molenaar-Kuijsten, Verheijen Remy B, Jacobs Bart A W, Bas Thijssen, Hilde Rosing, Dorlo Thomas P C, Beijnen Jos H, Neeltje Steeghs, Huitema Alwin D R 27 Jan 2022, In: Therapeutic drug monitoring. 44 , p. 520-526 7 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not